Lasa Supergenerics Ltd (LASA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

Lasa Supergenerics Share Price

10.16 0.16 1.60%
as on 05-Dec'25 12:16

Lasa Supergenerics Ltd (LASA) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 540702 | NSE: LASA | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Lasa Supergenerics

Based on:

M-Cap below 100cr DeciZen not available

asa Supergenerics stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
50.1 Cr.
52-wk low:
8.2
52-wk high:
31.4

Is Lasa Supergenerics Ltd an attractive stock to invest in?

1. Is Lasa Supergenerics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lasa Supergenerics Ltd is a below average quality company.

2. Is Lasa Supergenerics Ltd undervalued or overvalued?

The key valuation ratios of Lasa Supergenerics Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Lasa Supergenerics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Lasa Supergenerics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lasa Supergenerics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lasa Supergenerics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 0%0%14.5%12.8%-3.7%6.8%17.1%-3.4%-23.9%-13.2%-
Value Creation
Index
NANA0.0-0.1-1.3-0.50.2-1.2-2.7-2.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0019924417016720213713010495
Sales YoY Gr.-NANA22.5%-30.4%-1.4%21%-32.2%-5.5%-19.5%-
Adj EPS 00501.55.4-5.215.60.1-4.8-3.1-7.2
YoY Gr.-NANA-98.9%-196.7%NA475.3%-97.9%-4091.7%NA-
BVPS (₹) 0-60.210,983.351.346.134.839.131.523.619.311.3
Adj Net
Profit
002.512.3-11.9422.70.6-24-15.6-36
Cash Flow from Ops. 0-0.4-340.440.713.641.39.2-17.32.1-
Debt/CF from Ops. 0-1-38.62.62.13.60.52.2-1.310.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA-9.3%-19.8%-19.5%
Adj EPS NANA-182.3%NA
BVPSNA-16%-21%-18.3%
Share Price - -34.4% -32% -61%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
006.612.8-10.73.215.10.4-17.4-14.5-47.3
Op. Profit
Mgn %
002316.96.718.223.312.3-3.62.2-0.3
Net Profit
Mgn %
001.35.1-72.411.20.5-18.5-14.9-38
Debt to
Equity
0-1.22.10.90.80.30.10.10.20.20
Working Cap
Days
0066138206169118147123130110
Cash Conv.
Cycle
00275339-018413329-16

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -19.81%

Sales growth is not so good in last 4 quarters at -7.94%

Latest Financials - Lasa Supergenerics Ltd.

Standalone Consolidated
TTM EPS (₹) -7.2 -
TTM Sales (₹ Cr.) 95.3 -
BVPS (₹.) 11.3 -
Reserves (₹ Cr.) 6 -
P/BV 0.89 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 8.21 / 31.40
All Time Low / High (₹) 8.21 / 214.90
Market Cap (₹ Cr.) 50.1
Equity (₹ Cr.) 50.1
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Lasa Supergenerics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *20.7120.6620.6620.6620.6620.6620.6620.6620.6620.66
* Pledged shares as % of Promoter's holding (%)

Valuation of Lasa Supergenerics - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Lasa Supergenerics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0198.75243.53169.57167.26202.38137.13129.57104.34
Operating Expenses 0153.23202.26158.52137.29155.17121.11136.17102.11
Manufacturing Costs09.5613.9212.6815.7517.5112.4013.9315.33
Material Costs0130.89171.51127.9594.65112.3591.29106.1175.22
Employee Cost 09.5510.2711.7413.4214.017.156.355.37
Other Costs 03.236.566.1613.4711.3010.279.776.20
Operating Profit 045.5241.2611.0529.9747.2116.02-6.602.22
Operating Profit Margin (%) -22.9%16.9%6.5%17.9%23.3%11.7%-5.1%2.1%
Other Income 02.173.490.540.230.180.281.840.10
Interest 011.6811.358.388.122.060.064.191.99
Depreciation 07.6918.1719.3117.3415.8214.5113.4210.67
Exceptional Items 0-26.190000-7.86-19.90-8.77
Profit Before Tax 02.1415.23-16.104.7429.49-6.14-42.27-19.11
Tax 0-0.222.89-4.071.116.71-0.81-3.642.62
Profit After Tax 02.3612.34-12.033.6322.78-5.33-38.62-21.73
PAT Margin (%) -1.2%5.1%-7.1%2.2%11.3%-3.9%-29.8%-20.8%
Adjusted EPS (₹)0.0472.55.4-5.30.95.6-1.1-7.7-4.3
Dividend Payout Ratio (%)0%0%0%0%0%4%-23%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.0554.92117.34105.30141.47158.92157.88118.2996.68
Share Capital 0.050.0522.8622.8640.6740.6750.1050.1050.10
Reserves 054.8794.4882.43100.79118.24107.7868.1846.58
Minority Interest000000000
Debt0.35103.8790.1068.7334.480000
Long Term Debt0.3580.6860.2745.7214.140000
Short Term Debt023.1929.832320.340000
Trade Payables025.3847.9459.6733.7312.7216.919.4314.05
Others Liabilities 044.0831.4021.7819.1436.2234.3836.1440.14
Total Liabilities 0.40228.25286.78255.47228.81207.86209.17163.85150.87

Fixed Assets

Gross Block0131.61200.58211.87219.54226.12233.77228.70230.18
Accumulated Depreciation012.7830.9450.1767.3583.1796.49109.74120.42
Net Fixed Assets 0118.83169.64161.69152.19142.95137.28118.96109.76
CWIP 029.517.247.21004.584.642.51
Investments 0000000.380.390
Inventories033.4642.2331.6026.3017.2611.5013.9019.04
Trade Receivables034.9742.1528.8820.6514.7718.562.483.59
Cash Equivalents 0.051.162.632.696.064.4017.222.391.50
Others Assets 0.3510.3122.8823.4123.6128.4819.6621.0914.47
Total Assets 0.40228.25286.78255.47228.81207.86209.17163.85150.87

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -0.35-340.3540.6613.6241.319.21-17.302.14
PBT 02.1415.23-16.104.7429.491.72-22.37-19.11
Adjustment 017.3326.0727.2025.2717.756.50-4.078.42
Changes in Working Capital -0.35-22.141.3433.11-16.01-5.933.599.1812.83
Tax Paid 0-0.33-2.30-3.54-0.370-2.59-0.040
Cash Flow From Investing Activity 00.38-44.41-7.34-1.63-3.60-2.9111.19-0.40
Capex 0-1.69-46.71-11.33-0.63-6.592.584.830.66
Net Investments 00-1.12-0.13-1.232.93-5.594.561.09
Others 02.073.414.120.230.060.101.80-2.15
Cash Flow From Financing Activity 0.400.054.41-33.40-9.85-36.44-0.04-4.16-1.93
Net Proceeds from Shares 0.05029.52032.500000
Net Proceeds from Borrowing 0.356.18-20.41-14.55-31.58-14.14000
Interest Paid 0-11.68-11.34-12.02-8.10-1.96-0.04-4.16-1.93
Dividend Paid 000000000
Others 05.556.65-6.83-2.67-20.34000
Net Cash Flow 0.05-2.570.35-0.082.151.276.26-10.27-0.19

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)08.6514.33-10.812.9415.17-3.37-27.97-20.22
ROCE (%)014.4512.8-3.736.7717.14-3.41-23.94-13.23
Asset Turnover Ratio01.910.950.630.690.930.660.690.66
PAT to CFO Conversion(x)N/A-1.273.27N/A3.751.81N/AN/AN/A
Working Capital Days
Receivable Days05857765432443011
Inventory Days05656796339383658
Payable Days0717815318075594557

Lasa Supergenerics Ltd Stock News

Lasa Supergenerics Ltd FAQs

The current trading price of Lasa Supergenerics on 05-Dec-2025 12:16 is ₹10.16.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Lasa Supergenerics stood at ₹50.10.
The latest P/E ratio of Lasa Supergenerics as of 04-Dec-2025 is 0.00.
The latest P/B ratio of Lasa Supergenerics as of 04-Dec-2025 is 0.89.
The 52-week high of Lasa Supergenerics is ₹31.40 and the 52-week low is ₹8.21.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Lasa Supergenerics is ₹95.29 ( Cr.) .

About Lasa Supergenerics Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×